Last Chance to Register for MDRP 2014

Hurry! There is still time left to register for the
19th Annual Medicaid Drug Rebate Program Summit!
Online registration closes this Sunday, September 14th.
Register Now >>

 

 

MDRP 2014 begins in just 4 days! Don't miss out on THE authoritative event for everything government pricing, rebates and regulation. Join 70+ speakers, 500+ MDRP executives, 20+ solution providers in the only event where the government programs and pricing industry comes together each year to debate and create a roadmap to operational solutions.

Don't miss out on these key highlights on the MDRP 2014 agenda:

• 2 Keynote speakers discussing the true impact of the ACA and Medicaid reform
• Legal & Compliance Track dedicated to overcoming challenges in the current legal landscape and ensuring compliance with government program mandates affecting manufacturers
• CLE Accreditation - Earn continuing Legal Education (CLE) credits
• Four pharma case studies from AstraZeneca, Mylan and GSK
• Pre-conference workshop dedicated to Generic Drug Manufacturers
• Direct access to State Rebating Representatives in State Dispute Resolution Meetings
• And more!
 

Create Your Own Personal Agenda Here to Follow All the Exciting Details.

 
Online registration will close Sunday, September 14th so register now! Remember to take an extra $100 off registration rates with the code XP1958BLOG. On-site registration will be available all three days of the conference.

Don't miss out! Be part of the go-to industry event and leave armed with the tools and ideas to optimize your government pricing operations.

Q&A with Miree Lee of M. Lee Consulting, LLC - A Speaker at IIR's Gross-To-Net Accounting Forum

• 
  

At the 2nd Annual Gross-To-Net Accounting Forum, Miree Lee will be leading a workshop on the Impact of the MDRP AMP Final Rule on Accruals. With the CMS AMP Final Rule scheduled to be released in May, attendees of this workshop will learn about the many variables within the rule that alter government payer forecasting, gross-to-net and accrual calculations. Different types of manufacturers must also consider how their products and their distribution model are specifically impacted.

Key considerations of the final rule, impact for each:

• Pharmaceutical Price Points (AMP, BP, ASP, NFAMP, 340B, etc.)
• Overview of Various Government Programs
• Requirements under Medicaid Drug Rebate Program
• What is AMP?
• What are the inclusion and exclusion filters?
• How is AMP used?
• What is BP?
• What are the inclusion and exclusion filters?
• How is BP used?
• What is the URA?
• What are some potential changes in AMP, BP and URA?
• How do companies accrue?
• How does Medicaid expansion impact accruals?
• Managed Care Medicaid and Duplicate Discounts
• Other changes in Medicaid that may impact accruals

Q&A:

1. How feasible is collaboration between managed markets, commercial, government programs and Finance?  

Collaboration takes on different forms for different companies.  There isn't a "one size fits all" methodology except that the core principle of collaboration is a critical necessity for government pricing/program compliance.  Some companies identify and memorialize the collaboration process via formal process methodology document which outlines the tactical activities of collaboration (e.g. roles, responsibilities, timelines, specific reports and data, meeting schedule, etc.).  Other companies may adopt a less formal process whereby key persons of each department are involved in providing the proper information to the pricing department or responsible individual to ensure government pricing/program compliance.  Depending upon the size, structure, product mix, complexity of business and various other factors, cross functional collaboration may look different company-to-company. 

2. Key questions to ask before investing and building an automated GTN or GP system? 

Number of products, number of NDCs, annual sales, number of direct and indirect customers, classes of trade for direct and indirect customers, number and types of discount contracts, rebate or chargeback, tiered or market share based contracts, volume based contracts, formulary status requirements, bundles, stacked discounts, types of fees - bona fide or not. 

3. How to accrue and forecast patient/ payer related items? What critical/ essential information is required and what aspects you can’t afford to overlook.

• Intimate knowledge of the competitive market
• Shifts in market share and causes for the shifts (pricing, special contracts, supply, reimbursement)
• Thorough understanding of payers and changes in payor reimbursement
• Changes in payor coverage and patient population (e.g. Medicaid expansion, shifts in payor mix)
• Changes in mandatory discount/rebate liability (e.g. Medicaid URA increases substantially or 340B or FSS price decreases substantially)
• Price protection and how price protection is calculated

To hear more from Miree, please join us at the Gross-To-Net Accounting Forum, June 17-18 in Philadelphia, PA. 

Register now and save an additional $100 off the current rate when using the code: XP1911BLOG

Your Webinar Invitation: Gross-to-Net Forecasting and Reporting Impacts

Pharmaceutical Gross-to-Net professionals are managing a dynamic environment with government legislation, commercial contracting demands and accounting/compliance standards.

 This Complimentary Webinar Will Address Key GTN Hot Topics:

· New Product Launch Revenue Recognition and Forecasting GTN
· Acquisition of Product — GTN processing, accounting and forecasting transition plans
· Returns Reserve — Critical considerations before you calculate
· Returns Reserve — Best Practice Methodologies
· Late Stage Product Accounting & Forecasting considerations
· LOE Reserve — Demand, Pipeline, Returns accrual adjustments

You will hear from GTN Forum advisors David Levi from Bristol-Myers Squibb and Jennifer Sharpe from Professional Provider Services, Inc. Together, David and Jen will pool their personal experience, network of clients and industry colleagues to provide the audience with best practices and an interactive discussion on these key product milestones.

Space is limited, reserve your seat today.

DATE: May 8, 2013
TIME: 11:00am-12pm EST
SPEAKERS: David Levi Executive Director Finance US Controller & Global Commercial Controls, Bristol-Myers Squibb

Jennifer Sharpe Director of Managed Markets Projects & Business Development, Professional Provider Services, Inc.

COST: Complimentary

To find out more about the 2013 program, download the agenda.

As a reader of Healthcare Insights blog, you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you this June!

Best,

The Pharmaceutical Accounting, Financial, & Reporting Team

Visit our homepage
Follow us on Twitter